NEW YORK (GenomeWeb News) – An activist investment fund disclosed a 7.3 percent stake in Hologic and called for continued disclosure of the company's plans to pay down its debt and return cash to its shareholders.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.